Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kissei reports more new agents for treating diabetic complications

Aug. 20, 1998

Implanon found to be as effective as Norplant but easier to insert and remove

Aug. 19, 1998

Anastrozole, a potent aromatase inhibitor, is effective against postmenopausal endometriosis

Aug. 19, 1998

First filing for Novo Nordisk's fast-acting insulin analogue

Aug. 18, 1998

Insulin-sensitizing guanidine compounds discovered by Yamanouchi

Aug. 18, 1998

Otsuka adds new antidiabetic candidates to R&D pipeline

Aug. 18, 1998

TR1, new member of the TNFR superfamily and target for treating metabolic bone diseases

Aug. 18, 1998

L-Glutamine therapy beneficial for sickle cell anemia

Aug. 18, 1998

EC approval granted for Lilly's SERM, Evista

Aug. 17, 1998

Otsuka describes antihyperglycemic effects of coumarin derivatives

Aug. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...